NDC codes

FDA NDC Directory
Product NDC (as listed)68254-5010Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68254-5010Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
68254-5010-1682545010016825450100130 TABLET, FILM COATED in 1 BOTTLE (68254-5010-1)Marketed from Jul 7, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Teriflunomide
Generic name (nonproprietary)
teriflunomide
Active ingredients
Teriflunomide — 14 mg/141
Dosage form
Tablet, Film coated
Route
Oral
Labeler
CONCORD BIOTECH LIMITEDNDC labeler code 68254
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 218663
Marketing start
Listing expires
Other FDA classes
Dihydroorotate Dehydrogenase Inhibitors (Mechanism)
Identifiers
Product ID 68254-5010_5664923f-8420-403f-ab1d-6487ffaa2790SPL ID 5664923f-8420-403f-ab1d-6487ffaa2790SPL set ID 2d2724f6-8812-4a26-b2ec-936b71f868e1RxCUI 1310525, 1310533UNII 1C058IKG3BUPC 0368254501316
Pharmacologic class
Pyrimidine Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468254501001 followed by a unit qualifier and the quantity

Package 68254-5010-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide is pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68254-5010

What is NDC 68254-5010?
68254-5010 is the product NDC for Teriflunomide, Teriflunomide 14 mg/141 tablet, film coated, listed with the FDA by CONCORD BIOTECH LIMITED. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Teriflunomide.
What is the active ingredient?
Teriflunomide.
Who is the labeler?
CONCORD BIOTECH LIMITED, NDC labeler code 68254. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Teriflunomide?
33 other product NDCs are listed under this name. See all Teriflunomide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Teriflunomide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCivica Script LLC82249-11182249-0111-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralCivica Script LLC82249-11282249-0112-30
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCONCORD BIOTECH LIMITED68254-501368254-5013-01
TeriflunomideTeriflunomide 7 mg/1TabletOralNatco Pharma USA LLC69339-16969339-0169-0369339-0169-0969339-0169-93
TeriflunomideTeriflunomide 14 mg/1TabletOralNatco Pharma USA LLC69339-17069339-0170-0369339-0170-0969339-0170-93
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralAvKARE42291-83042291-0830-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralAvKARE42291-83142291-0831-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralBiocon Pharma Inc.70377-01870377-0018-1170377-0018-91
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralBiocon Pharma Inc.70377-01770377-0017-1170377-0017-91
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCamber Pharmaceuticals, Inc.31722-24631722-0246-30

All 34 Teriflunomide NDCs

Other NDCs under ANDA 218663

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218663
ProductStrengthForm · routeLabelerProduct NDC
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCONCORD BIOTECH LIMITED68254-5013

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in